The Estée Lauder Companies Inc.
$99.46-$2.31 (-2.3%)
Last close · Data as of Nov 20, 2026
- Market cap
- $30.0B
- EV / EBITDA
- 250.3x
- Revenue
- $14.3B
- Net margin
- -7.9%
- ROCE
- -6.1%
Price chart
Technical chartScreen technicals →+14.8% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -6.3%
- 3M
- +3.4%
- 6M
- +27.2%
- 1Y
- +14.8%
- 5Y
- -71.8%
52-week range
Day change -$2.31 (-2.3%) from $102 to $99 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in EL, bought on each weekday since 2021.
News & filings
What The Estée Lauder Companies filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockConcernThe company made a net loss of 1.1 billion US dollars in fiscal 2025.
Strengths
No strength stands out for this company on the data on file.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide.
Read moreShow less
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. The company offers skin care products, including moisturizers, serums, cleansers, toners, eye care, body care, exfoliators, acne care and oil correctors, facial masks, and sun care products; and makeup products, such as foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, mascaras, and eyeshadows and eyeliners, as well as compacts, brushes, and other makeup tools. It also provides fragrance products in various forms comprising parfum, eau de parfum, eau de toilette, eau de cologne, and body spray, as well as lotions, creams, powders, candles and soaps; and hair care products, including shampoos, conditioners, styling products, treatment, finishing sprays, and hair colour products, as well as sells ancillary products and services. The company offers its products under the La Mer, Jo Malone London, TOM FORD, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, KILIAN PARIS, BALMAIN Beauty, Estée Lauder, Clinique, M·A·C, The Ordinary, Aveda, Bobbi Brown Cosmetics, Too Faced, Dr.Jart+, Bumble and bumble, Editions de Parfums Frédéric Malle, Smashbox, Darphin Paris, Lab Series, NIOD, Aramis, and GLAMGLOW brands. It sells its products through department stores, duty-free retailers, specialty multi retailers, online pure players, upscale perfumeries and pharmacies, and top-tier salons and spas, as well as direct-to-consumer businesses across freestanding stores, and brand websites and third-party online platforms. The Estée Lauder Companies Inc. was founded in 1946 and is headquartered in New York, New York.
- Sector
- Consumer Defensive
- Shares outstanding
- 359.8M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $30.0B
- P/B
- 7.8x
- EV / EBITDA
- 250.3x
- EV / Sales
- 2.6x
- P/S
- 2.1x
- 52-week high
- $119.61
- 52-week low
- $67.23
Profitability
- Operating margin
- 8.0%
- Net margin
- -7.9%
- EBITDA margin
- 1.0%
- ROE
- -29.3%
- ROCE
- -6.1%
- ROA
- -5.7%
- Asset turnover
- 0.72
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $14.3B
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -8.2%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- -6.9%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -390.5%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $670.0M
Solvency
- Current ratio
- 1.30
- Debt / Equity
- 2.45
- Debt / Assets
- 0.48
- CFO / Net profit
- -1.12
- Cash / Market cap
- 9.7%
Where the revenue went
FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.
| Line | FY2025 |
|---|---|
| Revenue | $14.3B |
| Cost of revenue | $3.7B |
| Gross profit | $10.6B |
| Operating expenses | $9.5B |
| Selling, general and administrative | $9.5B |
| Operating income | $1.1B |
| Interest and other | -$2.2B |
| Pretax income | -$1.0B |
| Tax and other | $93.0M |
| Net income | -$1.1B |
Revenue and net profit
Revenue fell 8.2% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $17.7B | $2.4B |
| FY2023 | $15.9B | $1.0B |
| FY2024 | $15.6B | $390.0M |
| FY2025 | $14.3B | -$1.1B |
Cash flows
FY2025: $1.3B from operations, $670.0M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $3.0B | $2.0B |
| FY2023 | $1.7B | -$1.6B |
| FY2024 | $2.4B | $1.4B |
| FY2025 | $1.3B | $670.0M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $14.3B-8.2%1Y
- EBITDA
- $146.0M-92.6%1Y
- Net profit
- -$1.1B-390.5%1Y
- Cash from operations
- $1.3B-46.1%1Y
- Free cash flow
- $670.0M-53.5%1Y
- Revenue CAGR, 3Y
- -6.9%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $14.3B | $146.0M | -$1.1B | $670.0M | -29.3% | -8.2% | -390.5% |
Monthly returns
Month-by-month returns of EL across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $19.9B |
| Current assets | $7.1B |
| Non-current assets | $12.8B |
| Liabilities | $16.0B |
| Current liabilities | $5.4B |
| Non-current liabilities | $10.6B |
| Equity | $3.9B |
| Paid-in capital | $7.0B |
| Retained earnings | $11.7B |
| Treasury stock | $13.7B |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Consumer Defensive companies placed by value, growth and quality; EL highlighted.
P/E against peers
EL has no positive P/E; the peer median is 17.5x.
Not shown (no positive earnings and no EV / Sales): The Estée Lauder Companies Inc., The Kraft Heinz Company.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| The Estée Lauder Companies Inc.ELthis company | $30.0B | — | 7.8x | -29.3% | 250.3x |
| The Hershey CompanyHSY | $37.1B | 42.0x | 8.0x | 19.0% | 21.6x |
| Sysco CorporationSYY | $35.6B | 19.4x | 19.4x | 99.9% | 11.8x |
| Kenvue Inc.KVUE | $32.4B | 22.0x | 3.0x | 13.7% | 13.4x |
| Kimberly-Clark CorporationKMB | $31.4B | 15.5x | 20.9x | 134.6% | 12.2x |
| The Kraft Heinz CompanyKHC | $26.6B | -4.6x | 0.6x | -14.0% | -12.8x |
| Bunge Global SABG | $25.1B | 30.8x | 1.6x | 5.1% | 16.2x |
| Constellation Brands, Inc.STZ | $23.7B | 14.1x | 2.9x | 20.9% | 11.0x |
| Dollar General CorporationDG | $22.8B | 15.1x | 2.7x | 17.8% | 11.5x |
| Peer median | — | 17.5x | 3.0x | 18.4% | 12.0x |
Year-to-date ROI
EL since 1 January, against earlier years.
Historical volatility
EL's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 20.0% |
| FY2023 | 11.1% |
| FY2024 | 10.0% |
| FY2025 | 8.0% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $14.3B |
| Cost of revenueCost Of Revenue | $3.7B |
| Gross profitGross Profit | $10.6B |
| Operating expensesOperating Expense | $9.5B |
| Selling, general and administrativeSelling General And Administration | $9.5B |
| Total expensesTotal Expenses | $13.2B |
| Operating incomeOperating Income | $1.1B |
| Interest and other | |
| Pretax incomePretax Income | -$1.0B |
| TaxTax Provision | $93.0M |
| Net incomeNet Income | -$1.1B |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $19.9B |
| Current assetsCurrent Assets | $7.1B |
| Non-current assetsTotal Non Current Assets | $12.8B |
| LiabilitiesTotal Liabilities Net Minority Interest | $16.0B |
| Current liabilitiesCurrent Liabilities | $5.4B |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $10.6B |
| EquityTotal Equity Gross Minority Interest | $3.9B |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $1.3B |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $1.3B |
| Net income, continuing operationsNet Income From Continuing Operations | -$1.1B |
| Depreciation and amortisationDepreciation And Amortization | $829.0M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $829.0M |
| Stock-based compensationStock Based Compensation | $304.0M |
| Deferred taxDeferred Tax | -$396.0M |
| Deferred income taxDeferred Income Tax | -$396.0M |
| Operating gains and lossesOperating Gains Losses | $95.0M |
| Gain loss on sale of PP&EGain Loss On Sale Of PPE | $19.0M |
| Gain loss on sale of businessGain Loss On Sale Of Business | — |
| Earnings losses from equity investmentsEarnings Losses From Equity Investments | — |
| Asset impairmentAsset Impairment Charge | $1.3B |
| Pension and employee benefit expensePension And Employee Benefit Expense | $76.0M |
| Change in working capitalChange In Working Capital | $349.0M |
| Other non-cash itemsOther Non Cash Items | -$62.0M |
| Investing cash flowInvesting Cash Flow | -$623.0M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$623.0M |
| Capital expenditureCapital Expenditure | -$602.0M |
| Capital expenditure (reported)Capital Expenditure Reported | -$602.0M |
| Sale of PP&ESale Of PPE | $3.0M |
| Net PP&E purchases and salesNet PPE Purchase And Sale | $3.0M |
| AcquisitionsPurchase Of Business | — |
| Net acquisitions and disposalsNet Business Purchase And Sale | — |
| Purchase of investmentsPurchase Of Investment | -$24.0M |
| Sale of investmentsSale Of Investment | — |
| Net investment purchases and salesNet Investment Purchase And Sale | -$24.0M |
| Purchase of intangiblesPurchase Of Intangibles | $0.00 |
| Net intangibles purchases and salesNet Intangibles Purchase And Sale | $0.00 |
| Other investing changesNet Other Investing Changes | — |
| Financing cash flowFinancing Cash Flow | -$1.1B |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$1.1B |
| Debt issuedIssuance Of Debt | $0.00 |
| Debt repaidRepayment Of Debt | -$505.0M |
| Net debt issuedNet Issuance Payments Of Debt | -$505.0M |
| Short-term debt issuedShort Term Debt Issuance | $0.00 |
| Short-term debt repaidShort Term Debt Payments | $0.00 |
| Net short-term debt issuedNet Short Term Debt Issuance | $0.00 |
| Long-term debt issuedLong Term Debt Issuance | $0.00 |
| Long-term debt repaidLong Term Debt Payments | -$505.0M |
| Net long-term debt issuedNet Long Term Debt Issuance | -$505.0M |
| Net common stock issuedNet Common Stock Issuance | -$35.0M |
| Common stock repurchasedCommon Stock Payments | -$35.0M |
| Share buybacksRepurchase Of Capital Stock | -$35.0M |
| Stock options exercisedProceeds From Stock Option Exercised | $15.0M |
| Dividends paidCash Dividends Paid | -$618.0M |
| Other financing chargesNet Other Financing Charges | -$1.0M |
| Change in cashChanges In Cash | -$495.0M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | 2,100.0% |
| Cash at the start of the yearBeginning Cash Position | $3.4B |
| Cash at the end of the yearEnd Cash Position | $2.9B |
| Free cash flowFree Cash Flow | $670.0M |
| Supplemental |
Learn while you research
Academy chapters picked for The Estée Lauder Companies Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Leverage RatiosDebt/Equity of 2.45 is elevated, understand what that means for solvency.6 min read
- 03 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
- 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read